|
|
|
|
Vol. 18, Issue 10, 4062-4073, October 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cancer Research UK Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, United Kingdom
Submitted May 24, 2007;
Revised July 18, 2007;
Accepted July 20, 2007
Monitoring Editor: Wendy Bickmore
CSM2, PSY3, SHU1, and SHU2 (collectively referred to as the SHU genes) were identified in Saccharomyces cerevisiae as four genes in the same epistasis group that suppress various sgs1 and top3 mutant phenotypes when mutated. Although the SHU genes have been implicated in homologous recombination repair (HRR), their precise role(s) within this pathway remains poorly understood. Here, we have identified a specific role for the Shu proteins in a Rad51/Rad54-dependent HRR pathway(s) to repair MMS-induced lesions during S-phase. We show that, although mutation of RAD51 or RAD54 prevented the formation of MMS-induced HRR intermediates (X-molecules) arising during replication in sgs1 cells, mutation of SHU genes attenuated the level of these structures. Similar findings were also observed in shu1 cells in which Rmi1 or Top3 function was impaired. We propose a model in which the Shu proteins act in HRR to promote the formation of HRR intermediates that are processed by the Sgs1-Rmi1-Top3 complex.
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).
Address correspondence to: Ian D. Hickson (ian.hickson{at}imm.ox.ac.uk)
Abbreviations used: DSB, double-strand break; FACS, fluorescent-activated cell sorting; HRR, homologous recombination repair; HU, hydroxyurea; MMS, methyl methane sulfonate.